Canpolat, Sinan; Ülker, Nazife; Yardımcı, Ahmet; Bulmuş, Özgür; Özdemir, Gökçen; Şahin, Zafer; Ercan, Zübeyde; Serhatlıoğlu, İhsan; Kaçar, Emine; Özcan, Mete; Türk, Gaffari; Özkan, Yusuf; Atmaca, Murad; Yılmaz, Bayram; Keleştimur, Haluk
(2016)
Agomelatine is an antidepressant with a novel mechanism of action. It is a melatonergic agonist for MT1 and MT2 receptors and a serotonin (5-HT2C) receptor antagonist. Agomelatine has been suggested not to have adverse ...